Algerians continue to shine abroad, in all areas. These people who carry a cause, an invention or a revolutionary idea that raises the Algerian flag, this is the scenario of Jamila Louahed.
The first name “Jamila” which translates “beautiful” and which carries a beautiful story and a beautiful accomplishment of the daughter of an Algerian immigrant, a young woman with ambitions that go beyond all limits. Post-doctoral fellow in the United States, Jamila Louahed has surpassed all obstacles, her weapon? his determination.
Jamila is the pride of her father, but also that of a nation, the Algerian is at the head of the large bio-pharmaceutical company in Belgium, namely R&D (Research and Development) of GSK Belgium; with a master’s degree in biotechnology in the Brussels Alma of UCLouvain, a doctorate and a post-doctorate in Philadelphia.
When the dream comes true
Dr. Jamila Louahed wanted to become a doctor, however, she wanted to gain financial independence quickly. This desire, which deviated her from her initial dream, did not take her away from fame, since thanks to her passion for life science, she took her dream of developing vaccines, especially against cancer, at GSK.
This consisted of characterizing the antigens present in cancer cells, with the hope of developing a vaccine that would allow them not to reappear in the future, for patients who have already had tumors. Arrived at phase 3, the results were not those expected, but that does not discourage her, she remains convinced that one day, it will materialize.
The crowning of his efforts
The Algerian researcher received the good news of the agreement of the administration by the World Health Organization (WHO) of the first vaccine against malaria (malaria), an unprecedented achievement in the medical field, signed by Dr. Louahed .
A big step forward despite the difficulty and complications that the development of a virus can experience, especially on an economic level, as was the case for the Coronavirus.
In the same context of Covid-19, the scientist explains the impact of the economic factor “this is the problem we have encountered with malaria, if we want to help these developing countries the model must be reviewed to allow the equitable access to immunization. All the more so now that this virus has no borders ”. We will certainly see his name make the headlines in the future.
–
